Crescita Therapeutics Stock Forecast, Price & News

-0.02 (-2.33 %)
(As of 04/13/2021 09:30 AM ET)
Today's Range
Now: C$0.84
50-Day Range
MA: C$0.84
52-Week Range
Now: C$0.84
Volume1,501 shs
Average Volume29,106 shs
Market CapitalizationC$17.34 million
P/E Ratio420.00
Dividend YieldN/A
Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products for the treatment and care of skin conditions, diseases, and their symptoms in Canada, the United States, and internationally. It owns various proprietary drug delivery platforms, including DuraPeel and MMPE that support the development of patented formulations, which facilitate the delivery of active drugs into or through the skin. The company's prescription products include Pliaglis, a topical local anesthetic cream that provides dermal analgesia on intact skin prior to superficial dermatological procedures; Flexicaine, an anesthetic formulation of lidocaine and tetracaine for the topical treatment of pain conditions; MiCal 1 that is in Phase II clinical trial for the treatment of moderate to severe plaque psoriasis; and MiCal 2, which is in preclinical stage to treat a dermatological skin condition. Its non-prescription skincare products comprise skincare products for aging, acne, rosacea, pigmentation, dehydration, and sensitivity under the Laboratoire Dr Renaud brand; a line of cosmeceutical products for anti-aging medical procedures under the Pro-Derm brand; and a line of products to target and treat various skincare concerns under the Alyria brand. The company has a collaboration agreement with Tetra Natural Health to develop Tetra's dermatology portfolio using the company's transdermal delivery technologies, multiplexed molecular penetration enhancer and DuraPeel; and a development and licensing agreement with Sundial Growers Inc. to develop cannabis and hemp topicals. Crescita Therapeutics Inc. was incorporated in 2016 and is headquartered in Laval, Canada.

Industry, Sector and Symbol

Industry Biotechnology
Year FoundedN/A



Sales & Book Value

Annual SalesC$15.64 million
Cash FlowC$0.68 per share
Book ValueC$1.02 per share



Market CapC$17.34 million
Next Earnings DateN/A
OptionableNot Optionable


Crescita Reports Q4 and Fiscal 2020 Results
March 24, 2021 |  finance.yahoo.com
Crescita Reports Third Quarter 2020 Results
November 12, 2020 |  finance.yahoo.com
Crescita Reports Second Quarter 2020 Results
August 12, 2020 |  finance.yahoo.com
Crescita Reports First Quarter 2020 Results
May 27, 2020 |  finance.yahoo.com
Crescita Reports Q4 and Fiscal 2019 Results
March 18, 2020 |  finance.yahoo.com
Pliaglis® finally available in Canada
March 10, 2020 |  finance.yahoo.com
Crescita Reports 2019 Third Quarter Results
November 19, 2019 |  finance.yahoo.com
Is Crescita Therapeutics (TSE:CTX) Using Too Much Debt?
November 19, 2019 |  finance.yahoo.com
See More Headlines


Overall MarketRank

0.63 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
-0.02 (-2.33 %)
(As of 04/13/2021 09:30 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CTX News and Ratings via Email

Sign-up to receive the latest news and ratings for CTX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Crescita Therapeutics (TSE:CTX) Frequently Asked Questions

What stocks does MarketBeat like better than Crescita Therapeutics?

Wall Street analysts have given Crescita Therapeutics a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Crescita Therapeutics wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has Crescita Therapeutics' stock been impacted by COVID-19 (Coronavirus)?

Crescita Therapeutics' stock was trading at C$0.80 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CTX shares have increased by 5.0% and is now trading at C$0.84.
View which stocks have been most impacted by COVID-19

Who are Crescita Therapeutics' key executives?

Crescita Therapeutics' management team includes the following people:
  • Mr. Daniel N. Chicoine B.Com., C.A., CPA, B.Comm., CPA, CA, Exec. Chairman (Age 66, Pay $208.27k)
  • Mr. Serge Verreault B.A., M.B.A., Pres & CEO
  • Mr. Jose DaRocha C.A., CPA, Chief Financial Officer
  • Dominic King-Smith, VP of Bus. Devel.

Who are some of Crescita Therapeutics' key competitors?

What other stocks do shareholders of Crescita Therapeutics own?

What is Crescita Therapeutics' stock symbol?

Crescita Therapeutics trades on the Toronto Stock Exchange (TSX) under the ticker symbol "CTX."

How do I buy shares of Crescita Therapeutics?

Shares of CTX and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Crescita Therapeutics' stock price today?

One share of CTX stock can currently be purchased for approximately C$0.84.

How much money does Crescita Therapeutics make?

Crescita Therapeutics has a market capitalization of C$17.34 million and generates C$15.64 million in revenue each year.

How many employees does Crescita Therapeutics have?

Crescita Therapeutics employs 62 workers across the globe.

What is Crescita Therapeutics' official website?

The official website for Crescita Therapeutics is www.crescitatherapeutics.com.

Where are Crescita Therapeutics' headquarters?

Crescita Therapeutics is headquartered at 7560 Airport Rd Unit 10, MISSISSAUGA, ON L4T 4H4, Canada.

How can I contact Crescita Therapeutics?

Crescita Therapeutics' mailing address is 7560 Airport Rd Unit 10, MISSISSAUGA, ON L4T 4H4, Canada. The company can be reached via phone at +1-905-6734295.

This page was last updated on 4/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.